Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer-guided concentration-controlled trials in autoimmune disorders

J McMichael1, R Lieberman, H Doyle

  • 1Transplantation Institute, University of Pittsburgh, Pennsylvania 15213.

Therapeutic Drug Monitoring
|December 1, 1993
PubMed
Summary

A novel intelligent dosing system (IDS) enables accurate and reproducible drug concentration control in randomized concentration-controlled clinical trials (RCCCTs). This approach efficiently evaluates potent immunosuppressants like FK-506 in autoimmune diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Bayesian approach to time-domain photonic Doppler velocimetry analysis.

The Review of scientific instruments·2025
Same author

New Constraints on the Melting Temperature and Phase Stability of Shocked Iron up to 270 GPa Probed by Ultrafast X-Ray Absorption Spectroscopy.

Physical review letters·2025
Same author

Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.

The Journal of urology·2023
Same author

Late diagnosis of intraplacental choriocarcinoma co-existing with fetomaternal haemorrhage causing fetal demise: A case report.

Case reports in women's health·2021
Same author

<i>Candida</i> chorioamnionitis associated with late stillbirth: A case report.

Case reports in women's health·2020
Same author

Out of our comfort zone.

British dental journal·2020

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Immunology

Background:

  • Randomized concentration-controlled clinical trials (RCCCTs) offer an alternative to standard dose-controlled studies for evaluating drug efficacy.
  • FK-506 is a potent immunosuppressive agent used in preventing graft rejection and treating immune-mediated disorders.

Purpose of the Study:

  • To implement an RCCCT design for evaluating FK-506 in autoimmune disorders.
  • To assess the accuracy and reproducibility of a novel FK-506 intelligent dosing system (IDS).

Main Methods:

  • Patients with autoimmune disorders were enrolled in an RCCCT.
  • A novel FK-506 intelligent dosing system (IDS) was used to guide drug administration to target concentration ranges.
  • The predictive performance of the IDS was evaluated based on accuracy and precision.

Related Experiment Videos

Main Results:

  • The FK-506 IDS demonstrated excellent predictive performance across all patients.
  • The mean prediction error (accuracy) of the IDS was -0.022 ng/ml.
  • The standard deviation of the prediction error (precision) was 0.119 ng/ml, indicating reproducibility.

Conclusions:

  • The FK-506 IDS is accurate and reproducible for use in autoimmune patients.
  • The RCCCT design, guided by an accurate and precise IDS, is an effective and cost-efficient method for evaluating potent and toxic drugs.
  • This approach enhances the ability to identify concentration-response relationships for immunosuppressive agents.